ICU Medical CL3931Recalls & reported problems
Icu Medical, Inc. · 8.5" (22 cm) Appx 1.0 ml, Ext Set w/MicroClave® Clear, ChemoLock™ Port, Spiros® w/Red Cap, Clamp · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00887709077201), received between Jan 27, 2020 and Sep 28, 2026 — classified as 6 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (6 reports).
60 other recalls cover devices cleared under the same FDA submission (K131549); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Fluid/Blood Leak6
Patient problems
- No Consequences Or Impact To Patient4
- Chemical Exposure2
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 28, 2026Fluid/Blood Leak
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50918483 ↗MalfunctionApr 30, 2021Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT INVOLVED A 8.5" (22 CM) APPX 1.0 ML, EXT SET W/MICROCLAVE® CLEAR, CHEMOLOCK¿ PORT, SPIROS® W/RED CAP, CLAMP. IT WAS REPORTED THAT ON THE PATIENT¿S 5TH, AND LAST, DAY OF R-EPOCH THE DEVICE WAS LEAKING FROM THE SPIROS END ONTO THE PATIENT'S BED. THE CHEMOTHERAPY INFUSING WAS DOXORUBICIN, ETOPOSIDE AND VINCRISTINE. THE PATIENT, AND AREA, WERE CLEANED UP PER THE CUSTOMER'S PROTOCOL. THE CHEMO SPILL WAS CLEANED UP PER FACILITY PROTOCOL. THE SPIROS WAS CONNECTED TO THE BAXTER ONELINK ON PATIENT'S PORTAL. THERAPY WAS ENDED; THERE WAS NO BLOOD LOSS OR BLEED BACK. NO HOLES WERE NOTED ON THE DEVICE. THERE WAS PATIENT INVOLVEMENT, BUT THERE WAS NO ADVERSE EVENT OR HARM ASSOCIATED WITH THE REPORTED EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11751932 ↗MalfunctionFeb 16, 2021Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT INVOLVED A 8.5" (22 CM) APPX 1.0 ML, EXT SET W/MICROCLAVE® CLEAR, CHEMOLOCK¿ PORT, SPIROS® W/RED CAP, CLAMP THAT AT 7:30-7:45AM LEAKED BUSULFAN ON THE PATIENT. IT WAS REPORTED THAT THE PATIENT CALLED THE NURSE AND IT WAS FOUND THAT THE PATIENT WAS COVERED WITH CHEMO, BUT NO VISIBLE AFFECTS WERE OBSERVED. THE PATIENT'S CHEMO TREATMENT WAS DISCONTINUED FOR THE DAY. A SPILL KIT WAS USED FOR CLEAN UP. THERE WAS PATIENT INVOLVEMENT, AND ALTHOUGH THERE WAS A REPORT OF A DELAY IN THERAPY, THERE WAS NO ADVERSE EVENT AND NO ONE HARMED AS A RESULT OF THE REPORTED EVENT.
Patient problems: Chemical Exposure; No Consequences Or Impact To Patient
MAUDE report 11333737 ↗MalfunctionAug 26, 2020Fluid/Blood Leak; Fluid/Blood Leak
A MEDSUN MANDATORY MEDWATCH REPORT WAS RECEIVED THAT STATED ¿THE RN CONNECTED A CHEMOTHERAPY LINE TO A PATIENT, AND LINE WAS FLUSHED MANUALLY. RN TIGHTENED ALL THE CONNECTIONS AND THE LINE WAS DOUBLE CHECKED PRIOR TO STARTING CHEMOTHERAPY. IMMEDIATELY UPON STARTING THE CHEMOTHERAPY, THE PATIENT REPORTED FEELING MOISTURE. THERE WAS A LEAK ON THE IV MICROCLAVE CLEAR WITH CHEMOLOCK CONNECTOR.¿ THE EVENT OCCURRED ON AN UNSPECIFIED DAY IN (B)(6) 2020 AND HAPPENED IN THE PATIENT¿S ROOM OF THE HOSPITAL. THERE WAS PATIENT INVOLVEMENT, HOWEVER, NO REPORT OF ADVERSE EVENT.
Patient problems: Chemical Exposure; No Consequences Or Impact To Patient
MAUDE report 10454799 ↗MalfunctionJun 11, 2020Fluid/Blood Leak; Fluid/Blood Leak
THE CUSTOMER REPORTED THAT 8.5" (22 CM) APPX 1.0 ML, EXT SET W/MICROCLAVE® CLEAR, CHEMOLOCK¿ PORT, SPIROS® W/RED CAP LEAKED CHEMOTHERAPY. IT WAS FURTHER DESCRIBED THAT AFTER CHEMOTHERAPY FINISHED, THERE WAS A WET LIQUID NOTICED AROUND THE CHEMOLOCK PORT FROM THE BACKSIDE OF PORT. THIS OCCURRED DURING PATIENT USE AFTER AN HOUR AFTER THE START. THE PATIENT WAS WASHED AND THE BED WAS CHANGED. THE CHEMO SPILL WAS CLEANED UP AS PER FACILITY PROTOCOL. THERE WAS A MINIMAL LOSS, THAT WAS FOUND STRAIGHT AWAY AND THE EXTENSION SET WAS REPLACED. THE TUBING WAS SET UP WITH STANDARD SETUP SALINE LINE AND CHEMO LINE IN THE EXTENSION SET IN RESPECTIVE PORTS, THERE WAS NO BLOOD LOSS OR BLEED BACK. THERE WAS NO ADVERSE EVENT AND NO HARM AS A RESULT OF THE EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10146169 ↗MalfunctionJan 27, 2020Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT INVOLVED A 8.5" (22 CM) APPX 1.0 ML, EXT SET W/MICROCLAVE® CLEAR, CHEMOLOCK¿ PORT, SPIROS® W/RED CAP, CLAMP, THAT WHEN ADMINISTERING MELPHALAN TO A HOSPITAL INPATIENT, VIA AN UNSPECIFIED PUMP, LEAKING WAS DISCOVERED COMING FROM THE BACKSIDE OF THE CHEMOLOCK PORT WHERE IT IS BONDED ON THE Y-SITE OF THE EXTENSION SET. THE TUBING SET UP WAS THE LINE WAS PRIMED WITH SALINE FROM THE RESCUE LINE, AND THEN ATTACHED TO THE PATIENT. THE CLINICIAN DID NOT PRIME AT THE CHEMOLOCK PORT. THE EXTENSION SET HAD BEEN IN USE FOR 1 HOUR AND THE LEAK WAS NOTED WHEN THE CLINICIAN CHECKED ON THE PATIENT AT 8AM. THERE WAS ONLY A SMALL AMOUNT OF LEAKAGE BEFORE IT WAS CAUGHT. IT WAS REPORTED THAT THE CHEMOTHERAPY MEDICATION CAME IN CONTACT WITH THE PATIENT AND THE CLINICIAN. THE PATIENT WAS WASHED WITH SOAP AND WATER AND THE SPILL WAS CLEANED UP PER FACILITY PROTOCOL. THE EXTENSION SET WAS REPLACED BUT THE DRUG WAS NOT REPLACED SINCE THERE WAS 100-125ML LEFT OF A 1000ML INFUSION WHEN THE LEAK OCCURRED. AS THE LEAK WAS NOT FROM THE BAG SIDE (THAT CHEMOLOCK ATTACHMENT WAS PATENT) THE CHEMOLOCK EXTENSION SET WAS REPLACED AND THE REMAINDER OF THE DRUG WAS INFUSED WITHOUT INCIDENT. THERE WERE NO DEFEC
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9634266 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K131549. One submission often covers many models, so check the product and lot details in each record.
- Z-3159-2026 · May 12, 2026 · Open, ClassifiedOncology sets with drip chambers
- Z-3161-2026 · May 12, 2026 · Open, ClassifiedIV Sets with drip chambers
- Z-2210-2026 · Mar 24, 2026 · Open, ClassifiedOncology Kit w/60" (152 cm) Appx 2.2 ml, Smallbore Ext Set w/ChemoLock Port, Clamp, Anti-Siphon Valve, Spiros; ChemoLock; Syringe Transfer Set w/MicroClave, ChemoLock Port, REF: CL
- Z-0365-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemosafeLock Vial Adapter REFs: KL-VA001U3 KL-VA002U3 KL-VA131U3 KL-VA201U3 KL-VA202U3 KL-VA321U3
- Z-0328-2026 · Sep 8, 2025 · Open, ClassifiedChemoLock Bag Spike, 01 units REF: CL-10-10
- Z-0341-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Bag Spike REF: CL-10
- Z-0347-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Vial Spike, 20mm REF: CL-80S
- Z-0357-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Port w/Spiros, Red Cap REF: CL-35
- Z-0350-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Port REF: CL2100
- Z-0351-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical 21" Ext Set w/ChemoLock Port, Clamp, Graduated Connector REF: CL3360
- Z-0343-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Universal Vented Vial Spike REF: CL-70
- Z-0345-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Vented Vial Spike, 13mm REF: CL-72
- Z-0334-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical Oncology Kit w/31" (79 cm) 20 Drop Admin Set w/Integrated ChemoLock" Port Drip Chamber, Spiros"; ChemoLock"; ChemoLock" Universal Vented Vial Spike; Bag Hanger REF: C
- Z-0356-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical Syringe Transfer Set w/MicroClave, ChemoLock Port REF: CL-34
- Z-0362-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical Oncology Kit w/2 ChemoLock", 13mm Closed Vial Spike w/ChemoLock" Port, ChemoLock" Bag Spike, Ext Set w/ChemoLock" Port, Clamp, Graduated Adapter REF: CL4188
…and 45 more.
Other Closed antineoplastic and hazardous drug reconstitution and transfer system devices
- BD PhaSeal 515003BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall183 reports
- BD PhaSeal 515056BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall159 reports
- BD PhaSeal Optima 515070BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall154 reports
- Alaris 10012241-0500BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall138 reports
- BD PhaSeal 515005BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall128 reports
- ICU Medical CL3011Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls26 reports
- BD PhaSeal Optima 515052BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall114 reports
- ICU Medical CL3511Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls6 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page